Infectious Diseases Associates of Central Virginia

Lynchburg, Virginia 24501

0 studies enrolling now · 5 studies all time

What they study most

Covid19, Hepatitis C, Human Immunodeficiency Virus, Mild-to-moderate COVID-19, Recurrent C. Difficile Infection

Studies at this site

• A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) — Stopped early
• Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
• Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US) — Completed
• A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 — Completed
• Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing — Completed